145 related articles for article (PubMed ID: 25752295)
1. Oral squamous cancer cell exploits hnRNP A1 to regulate cell cycle and proliferation.
Yu C; Guo J; Liu Y; Jia J; Jia R; Fan M
J Cell Physiol; 2015 Sep; 230(9):2252-61. PubMed ID: 25752295
[TBL] [Abstract][Full Text] [Related]
2. HnRNP L is important for the expression of oncogene SRSF3 and oncogenic potential of oral squamous cell carcinoma cells.
Jia R; Zhang S; Liu M; Zhang Y; Liu Y; Fan M; Guo J
Sci Rep; 2016 Nov; 6():35976. PubMed ID: 27808105
[TBL] [Abstract][Full Text] [Related]
3. Acylglycerol kinase promotes the proliferation and cell cycle progression of oral squamous cell carcinoma.
Liu G; Ren X; Gao C; Zhang W
Mol Med Rep; 2015 Aug; 12(2):2225-30. PubMed ID: 25872568
[TBL] [Abstract][Full Text] [Related]
4. CD44 alternative splicing and hnRNP A1 expression are associated with the metastasis of breast cancer.
Loh TJ; Moon H; Cho S; Jang H; Liu YC; Tai H; Jung DW; Williams DR; Kim HR; Shin MG; Liao DJ; Zhou J; Shi W; Zheng X; Shen H
Oncol Rep; 2015 Sep; 34(3):1231-8. PubMed ID: 26151392
[TBL] [Abstract][Full Text] [Related]
5. microRNA-26a and -584 inhibit the colorectal cancer progression through inhibition of the binding of hnRNP A1-CDK6 mRNA.
Konishi H; Fujiya M; Ueno N; Moriichi K; Sasajima J; Ikuta K; Tanabe H; Tanaka H; Kohgo Y
Biochem Biophys Res Commun; 2015 Nov; 467(4):847-52. PubMed ID: 26494299
[TBL] [Abstract][Full Text] [Related]
6. Expression and effect of heterogeneous nuclear ribonucleoprotein A2/B1 in tongue squamous cell carcinoma.
Liu Y; Shen X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):633-640. PubMed ID: 37539565
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic Control of Cancer Cell Proliferation and Cell Cycle Progression by HNRNPK via Promoting Exon 4 Inclusion of Histone Code Reader SPIN1.
Li D; Guo J; Jia R
J Mol Biol; 2023 Mar; 435(6):167993. PubMed ID: 36736887
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous nuclear ribonucleoproteins A1 and A2 modulate expression of Tid1 isoforms and EGFR signaling in non-small cell lung cancer.
Chen CY; Jan CI; Pi WC; Wang WL; Yang PC; Wang TH; Karni R; Wang TC
Oncotarget; 2016 Mar; 7(13):16760-72. PubMed ID: 26919236
[TBL] [Abstract][Full Text] [Related]
9. hnRNP A1 promotes keratinocyte cell survival post UVB radiation through PI3K/Akt/mTOR pathway.
Feng J; Liao Y; Xu X; Yi Q; He L; Tang L
Exp Cell Res; 2018 Jan; 362(2):394-399. PubMed ID: 29229447
[TBL] [Abstract][Full Text] [Related]
10. Expression of growth arrest and DNA damage inducible 45a in human oral squamous cell carcinoma is associated with tumor progression and clinical outcome.
Zhang XY; ; Wang CQ; Liu GX; Zhou CJ; Wang ZG
J Cancer Res Ther; 2014 Nov; 10 Suppl():C108-13. PubMed ID: 25450267
[TBL] [Abstract][Full Text] [Related]
11. A truncated hnRNP A1 isoform, lacking the RGG-box RNA binding domain, can efficiently regulate HIV-1 splicing and replication.
Jean-Philippe J; Paz S; Lu ML; Caputi M
Biochim Biophys Acta; 2014; 1839(4):251-8. PubMed ID: 24530421
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of targeting cell division cycle associated 5 for oral squamous cell carcinoma.
Tokuzen N; Nakashiro K; Tanaka H; Iwamoto K; Hamakawa H
Oncotarget; 2016 Jan; 7(3):2343-53. PubMed ID: 26497678
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of hnRNP A1 gene in sporadic human colorectal cancers.
Ushigome M; Ubagai T; Fukuda H; Tsuchiya N; Sugimura T; Takatsuka J; Nakagama H
Int J Oncol; 2005 Mar; 26(3):635-40. PubMed ID: 15703818
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous nuclear ribonucleoprotein A1 post-transcriptionally regulates Drp1 expression in neuroblastoma cells.
Park SJ; Lee H; Jo DS; Jo YK; Shin JH; Kim HB; Seo HM; Rubinsztein DC; Koh JY; Lee EK; Cho DH
Biochim Biophys Acta; 2015 Dec; 1849(12):1423-31. PubMed ID: 26518267
[TBL] [Abstract][Full Text] [Related]
15. SRSF5 functions as a novel oncogenic splicing factor and is upregulated by oncogene SRSF3 in oral squamous cell carcinoma.
Yang S; Jia R; Bian Z
Biochim Biophys Acta Mol Cell Res; 2018 Sep; 1865(9):1161-1172. PubMed ID: 29857020
[TBL] [Abstract][Full Text] [Related]
16. Roles of heterogeneous nuclear ribonucleoproteins A and B in cell proliferation.
He Y; Brown MA; Rothnagel JA; Saunders NA; Smith R
J Cell Sci; 2005 Jul; 118(Pt 14):3173-83. PubMed ID: 16014382
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneous nuclear ribonucleoprotein G shows tumor suppressive effect against oral squamous cell carcinoma cells.
Shin KH; Kang MK; Kim RH; Christensen R; Park NH
Clin Cancer Res; 2006 May; 12(10):3222-8. PubMed ID: 16707624
[TBL] [Abstract][Full Text] [Related]
18. The human HECA interacts with cyclins and CDKs to antagonize Wnt-mediated proliferation and chemoresistance of head and neck cancer cells.
Dowejko A; Bauer R; Bauer K; Müller-Richter UD; Reichert TE
Exp Cell Res; 2012 Mar; 318(5):489-99. PubMed ID: 22100912
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
20. Aptamer BC15 against heterogeneous nuclear ribonucleoprotein A1 has potential value in diagnosis and therapy of hepatocarcinoma.
Li S; Wang W; Ding H; Xu H; Zhao Q; Li J; Li H; Xia W; Su X; Chen Y; Fang T; Shao N; Zhang H
Nucleic Acid Ther; 2012 Dec; 22(6):391-8. PubMed ID: 23062008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
